AQURE, Software version 2.3.0 and 2.3.1 Product Usage: The AQURE system is intended to let allow the management of analytical devices and operator profiles. The user can associate patient data with test data. The system shows test results. The system receives data from connected devices at the point-of care or laboratory. It can send test results to the HIS/LIS. The system lets the user send commands to selected devices. The system uses data related to the performance of devices, to tell users of issues to be managed. The AQURE system is intended for professional use.
Publicado el 9 de mayo de 2018 · Inicio del retiro: 27 de febrero de 2018
Resumen
FDA registra el retiro Z-1582-2018 de dispositivos médicos de Clase II, publicado el 9 de mayo de 2018 e iniciado el 27 de febrero de 2018. Empresa responsable: Radiometer Medical ApS; Estado: Finalizado; Cantidad reportada: 2; Lote: Version 2.3.0 and 2.3.1. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
There is a potential problem relating to the AQURE System, versions 2.3.0 and 2.3.1, that may result in patient mix-up.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Radiometer Medical ApS
- Distribuidor
- US Nationwide Distribution in the states to Georgia and Wisconsin.
- Lote
- Version 2.3.0 and 2.3.1
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- Denmark
Retiros relacionados
- FDAThe ABL90 FLEX and ABL90 FLEX PLUS analyzers are intended for use by trained technologists, nurses, physicians21 de octubre de 2026
- FDAABL800 FLEX Model Numbers 393-800 and 393-801 The ABL800 FLEX analyzers are intended for: " In Vitro testing31 de julio de 2024
- FDAAQURE REF 933-599 Software Versions 2.5.2 2.5.3 2.5.4 2.6.0 2.6.1 The AQURE system is intended to let you26 de abril de 2023
- FDARadiometer, REF:956-552, PIC050- Arterial Blood Sampler 1 X 2 mL, 80 IU electrolyte-balanced heparin. Not for25 de mayo de 2022
- FDABeijing Syntech Laser APOLLO JV+ Medical Platform surgical lasers9 de mayo de 2018
- FDAAnalyzer and Atellica IM 1600 Analyzer system for in vitro diagnostic testing of clinical specimens.9 de mayo de 2018
Preguntas sobre este retiro
¿AQURE, Software version 2.3.0 and 2.3.1 Product Usage: The AQURE system is intended to let allow the management of analytical devices and operator profiles. The user can associate patient data with test data. The system shows test results. The system receives data from connected devices at the point-of care or laboratory. It can send test results to the HIS/LIS. The system lets the user send commands to selected devices. The system uses data related to the performance of devices, to tell users of issues to be managed. The AQURE system is intended for professional use. fue retirado del mercado?
Sí. FDA publicó el retiro Z-1582-2018 el 9 de mayo de 2018. Peligro reportado: There is a potential problem relating to the AQURE System, versions 2.3.0 and 2.3.1, that may result in patient mix-up.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter